Share Name Share Symbol Market Type Share ISIN Share Description
Kromek Group Plc LSE:KMK London Ordinary Share GB00BD7V5D43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -2.59% 9.40 9.30 9.50 9.90 9.40 9.55 2,181,898 15:52:24
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 12.1 -6.1 -1.1 - 41

Kromek Share Discussion Threads

Showing 4826 to 4848 of 6725 messages
Chat Pages: Latest  197  196  195  194  193  192  191  190  189  188  187  186  Older
in Nov last year DARPA and the US Defense Department put out a solicitation to all US tech companies to attempt.....Again...
to develop a 'lab in a Box' fully automatic multi Patho/Virus/Bacteria Airborne system.
Under the SenSARS project, I've read since then that some companies that meet certain very strict requirements were elegble to be awarded 500k US grants with another 500k on milestones being meet.

This against Kromek's is it 13 million now?

They are very keen to get this technology up and running and the tech hasn't been there up to recently to achieve their goals.
So any Bio Covid virus other detection units that I'm sure we will read about in the future have to be 'lab in a box' Gold standard PCR+ they already use/have filter collect- send to lab set ups now.

Kromek are miles ahead in their development and have met all DARPAS milestones so far....the others if they do appear are at early prof of concept stage I would imagine.

So its probably prudent for any serious analyst to assume Kromek could have competition in a couple of years?

But the 20% share of the market for Bio units and the 500mil dollar (Paul hill ) global market are just estimates and could be much higher.

If you read any of the Biowatch US news they talk of multi year contracts of multi billion dollar sizes to role out this bio protection across US cites.

Developments in Gene sequencing is not standing still...the UK tech that Kromek are using(my assumption) for example has been vastly improved performance / sensitivity & time wise since the start of Kromek's project.
As you might have noticed the detection times mentioned by Kromek are now down to 30 mins or less.

There appears to be many overlapping US military/gov/security requirements and 'wants' that it's only a matter of time untill we hear of a Kromek prototype unit being shipped to the US for field trails there.


'The SenSARS project aims to identify SARS-CoV-2 signatures suitable for rapid indoor air monitoring and develop a TRL-4 prototype sensor.

ARLINGTON, Va. – U.S. military researchers are asking industry to develop technologies for sensors able to detect low concentrations if airborne viruses in room-size spaces within seconds to minutes to help detect the presence of pathogens like the COVID-19 coronavirus and prevent its spread.

QuePassa - Are you implying KMK's Covid detector could be outright fraud a la Theranos? What are you trying to say here? edit: not surprised you deleted your post you utter muppet
There isn’t a comparable detector out there....
Analyst Peel Hunt estimates Kromek could gain a 20% market share of the annual market for the detector. (£25m annual profit). Who’s selling the remaining 80%????
I doubt companies like this would think twice about ordering a detector per floor to avoid wearing face masks...

Hi - what are your main assumptions in your projection of 70% share price rise ? I see much greater potential but haven’t done a detailed forecast at this stage ? Thanks
Feeble attempt to deramp a stock up 10%. The price and volume shows this is now in play.I can see this up 70% in six months
AQC888 and 33mick - good posts from both, appreciate it.

The presentation really helped me to see the whole company and the exciting potential in all of their areas.

For the timelines, I was like "yep, that's what I thought".

For me, Arnab came across as a bit more street wise too, in terms of not promising the moon tomorrow.

They're dealing with many high level government agencies. He mentioned there are no standards for air monitoring of COVID. We're emerging from this pandemic and... anyway, suffice to say, I'm a confident holder now.


The ventilators are a perfect example of managements inability to communicate and manage investors expectations. I’m aware that at the start of the pandemic everybody including governments thought ventilators were the solution to people suffering with covid. However, as far as I’m aware the medical guidance changed and people suffering were given oxygen. Ventilators were only given to people in intensive care. There are not that many intensive care nurses and beds to go around. So having ventilators without the accompanying nurses was no use. So this was not a fault of Kromek.

What is categorically the fault of management is not updating shareholders with this very reasonable explanation of what happened.

The result of this is a very angry Que Passa who now disbelieves all the other things the management say.

Another example of the failure of Kromeks management. If you can see through all this inept management. Then I think there’s an interesting company. A company in which a very experienced Simon Thompson has clearly identified as having huge value and upside. The problem is new investors have is that there is a huge queue of old fed up investors waiting to exit and keeping the share price suppressed

I think a lot of investors will be displeased about the ventilators which were announced to great fanfare in April 2020.

Only yesterday, did we squeeze out of Kromek an answer as to how many had been made by them - which, according to dougmachin- was ZERO.

Kromek must have known about that for a long time but never had the courtesy to update the market.

Goes to the heart of credibility.


Huge amount of selling going on. Not quite sure how the share price is holding up so well. Clearly a lot of investors fed up with management playing games with expectations constantly.
I’ve also read the same over on lse, aqc888. 👍
Bit of a disappointing start to the day. When the print edition comes out on the weekend and people get a chance to read it over the weekend I’d expect to see it go up a bit more. Surprised not to see it hit 20p yet. I think there are a lot of frustrated holders who have been waiting to get rid of Kromek who are taking the chance to get out now, right at the time things are looking the most hopeful. You can see one long term apparent largish holder on the lse Kromek chat who’s exiting, with 33mick of course abusing him over his questioning of Kromeks managements competence.
Thanks for the write up Doug. This looks like it may be getting some traction now.
Yes a few impatient holders sell ahead of the value coming out. People are beginning to understand the variety of world beating tech here and next few months likely to be very interesting.
Excited by the move, then saw it was just a simon thompson ramp. As you were :)
So glad experience has paid off ignoring the fall yesterday and buying in.I have always wondered why good news and strong results results in a fall in the price.Maybe it just flushes outs the last of the sellers
Last interesting tip Simon Thompson made of mine was Metal Tiger 21p, which surged 20% in the morning after. His target was 33p. It reached 32p before falling back. I suspect based on this “strong buy” and unusually strong tip recommendation with “28p and well beyond” tip - this will go up significantly in the morning. It will then be in Fridays print edition. The price will continuously rise for a few days and touch 28p. I’ve put a buy order in for tomorrow to increase my holding by 30% with an 18.5p limit.

Last tip he made on Kromek on the 14/1 at 13.45p. Next day it went to 16.9p following week 23.5p. This time there will be a stronger reaction.

@ Abbynat. “Perhaps you wanted to hear contracts signed for billions and made yesterday!”
Now wouldn’t that have been nice! Don’t suppose your invested here are you? Just as well. Bye bye.

Is looking very exciting here. Multiple forecasts of share price heading towards 30p in short term. When more people study the potential here with risks diversified across various world leading products this could go anywhere. I suspect we may see short term small move to 20p ahead of streams of news in coming months. Like that the company doesn’t rush out news until there are material things to communicate to stakeholders. Anyone got targets for this one and on what basis ? GLA
Thank you Simon Thompson!!!!
Hallelujah!!!!!!!!!!! STRONG BUY 28p and WELL BEYOND

This will boom in the morning!

Cheers toptomcat

July 14, 2021
By Simon Thompson

"Backing a tech winner in the fight against Covid-19
A radiation detection technology company focused on the medical, security screening and nuclear markets is planning a commercial roll-out of its Covid-19 bio-security pathogen detectors. It is winning multiple contracts in other parts of the business, too."

Backing a tech winner in the fight against Covid-19
A radiation detection technology company focused on the medical, security screening and nuclear markets is planning a commercial roll-out of its Covid-19 bio-security pathogen detectors. It is winning multiple contracts in other parts of the business, too.

Order book covers 75 per cent of revenue estimates for 2021/22 financial year.
Successful pilot of Covid-19 pathogen detectors in UK airports, schools and retail outlets ahead of commercial roll-out.
Cutting edge CZT detectors being deployed in medical imaging scanners in multiple countries.
£20m worth of nuclear sector revenue in active procurement that could be delivered this year.

Kromek (KMK:15.75p), a Sedgefield-based radiation detection technology company focused on the medical, security screening and nuclear markets, has announced a raft of contract wins worth over £0.75m alongside annual results. The directors also revealed that the current order book covers 75 per cent of analysts’ revenue estimates for the 2021/22 financial year which point towards turnover rising from £10.4m to £15m.

Moreover, house broker Cenkos Securities expects gross margins to rise from 48 to 52 per cent, so with the benefit of a relatively fixed cost base last year’s Covid-19 impacted cash loss of £1.7m is forecast to produce a small adjusted cash profit. Paul Hill of Equity Development has similar estimates. It’s worth pointing out that forecasts don’t factor in any contribution from Kromek’s bio-security pathogen detectors which sample air and identify the presence of any biological pathogen including Covid-19.

The technology is based on Kromek’s work in developing a mobile bio-security system capable of detecting airborne pathogens for an agency of the US Department of Defence (DARPA). In the past month, DAPRA awarded Kromek a follow-on US$6m (£4.2m) contract to deliver an automated and fully mobile airborne pathogen detection system, and the company has been awarded a £349,000 contract from the UK Ministry of Defence. Chief executive Arnab Basu (pictured) says his company is in “serious discussions with multiple governments” and notes that “its unique set of IP isn’t reflected in the current valuation.” I concur, so much so that with a raft of positive news flow set to announced on multiple fronts in the coming months I expect the share price to re-rate markedly.

To quantify the size of the opportunity, Hill at Equity Development values the annual global market for the biological threat detection devices at £500m and believes that Kromek could win a 20 per cent share on a 25 per cent profit margin


Chat Pages: Latest  197  196  195  194  193  192  191  190  189  188  187  186  Older
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20230208 23:01:59